Medicare Enrolled
Dr. Sudad Louis, MD
Neurology · Sterling Heights, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Louis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Louis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Louis
Dr. Sudad Louis is a neurology specialist in Sterling Heights, MI, with 18 years of NPI registration. Based on federal Medicare data, Dr. Louis performed 979 Medicare services across 696 unique beneficiaries.
Between the years covered by Open Payments, Dr. Louis received a total of $10,449 from 55 pharmaceutical and/or device companies across 582 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Louis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 17% volume in MI
$10,449 industry payments
Medicare Practice Summary
Medicare Utilization ↗979
Medicare services
Top 17% in MI for neurology
696
Unique beneficiaries
$110
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~54 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
253 | $96 | $140 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
167 | $78 | $165 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
135 | $119 | $160 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
65 | $64 | $136 |
| New patient office visit, complex (60-74 min) | 55 | $166 | $250 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
51 | $10 | $80 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
43 | $168 | $410 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
34 | $137 | $300 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
31 | $346 | $735 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $129 | $225 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
24 | $141 | $295 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
24 | $96 | $194 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
20 | $303 | $645 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
18 | $11 | $35 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $106 | $291 |
| Injection, methylprednisolone acetate, 40 mg | 14 | $6 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,449
Total received (2018-2024)
Avg $1,493/year across 7 years
Top 21% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
582
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,287 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$162 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,722
2023
$2,295
2022
$2,091
2021
$1,655
2020
$722
2019
$471
2018
$494
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$436
Biogen, Inc.
$307
Novartis Pharmaceuticals Corporation
$196
Neurelis, Inc.
$190
ABBVIE INC.
$187
Lundbeck LLC
$169
PFIZER INC.
$151
Takeda Pharmaceuticals U.S.A., Inc.
$148
Neurocrine Biosciences, Inc.
$140
SK Life Science, Inc.
$102
Celgene Corporation
$99
Amneal Pharmaceuticals LLC
$79
Teva Pharmaceuticals USA, Inc.
$79
Alnylam Pharmaceuticals Inc.
$76
ARGENX US, INC.
$61
Otsuka America Pharmaceutical, Inc.
$56
Sumitomo Pharma America, Inc.
$42
Dexcom, Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
JAZZ PHARMACEUTICALS INC.
$22
Aucta Pharmaceuticals, Inc.
$20
Cycle Pharmaceuticals Inc
$19
Amgen Inc.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
MITSUBISHI TANABE PHARMA AMERICA, INC.
$16
Lilly USA, LLC
$15
Kyowa Kirin, Inc.
$14
Validus Pharmaceuticals LLC
$13
Top 3 companies account for 34.5% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$2,015
Biogen, Inc.
$744
Celgene Corporation
$543
Neurocrine Biosciences, Inc.
$530
SK Life Science, Inc.
$487
ABBVIE INC.
$443
Neurelis, Inc.
$398
Avanir Pharmaceuticals, Inc.
$387
Teva Pharmaceuticals USA, Inc.
$374
Takeda Pharmaceuticals U.S.A., Inc.
$367
PFIZER INC.
$335
Novartis Pharmaceuticals Corporation
$313
Otsuka America Pharmaceutical, Inc.
$281
Lilly USA, LLC
$276
Sunovion Pharmaceuticals Inc.
$246
Amgen Inc.
$244
GENZYME CORPORATION
$229
Alnylam Pharmaceuticals Inc.
$197
Supernus Pharmaceuticals, Inc.
$194
Lundbeck LLC
$169
E.R. Squibb & Sons, L.L.C.
$159
JAZZ PHARMACEUTICALS INC.
$148
ARGENX US, INC.
$120
Sumitomo Pharma America, Inc.
$98
Janssen Pharmaceuticals, Inc
$81
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
Amneal Pharmaceuticals LLC
$79
Biohaven Pharmaceuticals, Inc.
$78
Kyowa Kirin, Inc.
$69
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$64
Biohaven Pharmaceutical Holding Company Ltd.
$62
Corium, LLC
$61
Genentech USA, Inc.
$60
CATALYST PHARMACEUTICALS, INC.
$52
AQUESTIVE THERAPEUTICS, INC.
$47
Novo Nordisk Inc
$38
Aprecia Pharmaceuticals, LLC
$36
Greenwich Biosciences, Inc.
$31
IMPEL PHARMACEUTICALS INC.
$29
Dexcom, Inc.
$24
CSL Behring
$23
Adamas Pharmaceuticals, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
Eisai Inc.
$21
Aucta Pharmaceuticals, Inc.
$20
Cycle Pharmaceuticals Inc
$19
MITSUBISHI TANABE PHARMA AMERICA, INC.
$16
Alexion Pharmaceuticals, Inc.
$16
Ultragenyx Pharmaceutical Inc.
$16
Mitsubishi Tanabe Pharma America, Inc.
$16
Avion Pharmaceuticals
$16
Amarin Pharma Inc.
$15
AbbVie Inc.
$14
Validus Pharmaceuticals LLC
$13
Allergan, Inc.
$11
Top 3 companies account for 31.6% of all-time payments
Associated products mentioned in payments ›
AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BOTOX · Briviact · COMIRNATY · Dexcom G6 Transmitter · Dhivy · EMGALITY · EPIDIOLEX · Epidiolex · Equetro · FIRDAPSE · Fintepla · GAMMAGARD · GEMTESA · GOCOVRI · HYQVIA · Hizentra · INGREZZA · JARDIANCE · KESIMPTA · KISUNLA · KYNMOBI · Kerendia · LYRICA · Leqembi · MAYZENT · MOTEGRITY · Motpoly XR · NUEDEXTA · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OXTELLAR XR · Ongentys · Otezla · Ponvory · QULIPTA · RADICAVA · REXULTI · REYVOW · Radicava · Rystiggo · SOLIRIS · SYMPAZAN · Saxenda · Spritam · TECFIDERA · TRADJENTA · TRINTELLIX · TROKENDI XR · TYSABRI · Tascenso ODT · Trudhesa · UBRELVY · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vascepa · Vimpat · XIFAXAN · XYWAV · ZAVZPRET · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
257
Per 100K population
29.3
County median income
$76,399
Nearest hospital
THE BEHAVIORAL CENTER OF MICHIGAN
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Louis is a clinical cardiology specialist, with above-average Medicare volume (top 17% in MI), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Louis experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Louis performed 253 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Louis receive payments from pharmaceutical companies?
Yes. Dr. Louis received a total of $10,449 from 55 companies across 582 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Louis's costs compare to other neurologists in Sterling Heights?
Dr. Louis's average Medicare payment per service is $110. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Louis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Sterling Heights
Browse neurologists in Sterling Heights ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MI
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MI
Which MI neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology